Over @ weeks , numerical reductions from baseline in glycosylated hemoglobin ( HbA@c ) , fasting plasma glucose , and body weight were observed with dapagliflozin ( -@ % , -@ mmol/L , and -@ % , respectively ) versus slight numerical increases with placebo ( @ % , @ mmol/L , and @ % , respectively ) .